Differential protection in transgenic lines of NOD/Lt mice hyperexpressing the autoantigen GAD65 in pancreatic β-cells

Diabetes

Volumn 47, Issue 12, 1998, Pages 1848-1856

  Bridgett, Margot ^a   Cetkovic Cvrlje, Marina ^a   O'Rourke, Robert ^b   Shi, Yuguang ^b,d   Narayanswami, Sandya ^a   Lambert, Jeremy ^a   Ramiya, Vijayakumar ^c   Baekkeskov, Steinunn ^b   Leiter, Edward H ^a  

^a JACKSON LABORATORY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF FLORIDA   (United States)

^d ELI LILLY AND COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIGEN; GAMMA INTERFERON; INTERLEUKIN 10;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; ENZYME ACTIVITY; GENE INSERTION; GENE OVEREXPRESSION; HEMIZYGOSITY; INSULITIS; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; QUANTITATIVE ASSAY; TRANSGENIC MOUSE; Y CHROMOSOME;

EID: 0031738016     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.47.12.1848     Document Type: Article

References (44)

1. Gottlieb PA, Eisenbarth GS: Mouse and man: multiple genes and multiple autoantigens in the aetiology of type 1 DM and related autoimmune disorders. J Autoimmun 9:277-281, 1996
2. French M, Allison J, Dempsey M, Kay T, Cram D, Silva A, Harrison L, Thomas H, HM Georgiou, Lew A: Transgenic expression of mouse proinsulin-II prevents diabetes in nonobese diabetic mice. Diabetes 46:34-39, 1997
3. Birk OS, Douek DC, Elias D, Takacs K, Dewchand H, Gur SL, Walker MD, Vanderzee R, Cohen IR, Altmann DM: A role of hsp60 in autoimmune diabetes: analysis in a transgenic model. Proc Natl Acad Sci U S A 93:1032-1037, 1996
4. Muir A, Peck A, Claresalzler M, Song YH, Cornelius J, Luchetta R, Krischer J, Maclaren N: Insulin immunization of nonobese diabetic mice induces a protective insulitis characterized by diminished intraislet interferon-gamma transcription. J Clin Invest 95:628-634, 1995
5. Wegmann DR: The immune-response to islets in experimental diabetes and insulin-dependent diabetes-mellitus (Review). Curr Opin Immunol 8:860-864, 1996
6. Tian J: Modulating autoimmune responses to GAD inhibits disease progression and prolongs islet graft-survival in diabetes-prone mice. Nat Med 2:1348-1353, 1996
7. Kaufman DL, Clare-Salzler M, Tian J, Forsthuber T, Ting GSP, Robinson P, Atkinson MA, Sercarz EE, Tobin AJ, Lehmann PV: Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes. Nature 366:69-72, 1993
8. Tisch R, Yang X-D, Singer S, Liblau R, Fugger L, McDevitt H: Immune response to glutamic acid decarboxylase correlates with insulitis in nonobese diabetic mice. Nature 366:72-75, 1993
9. Tisch R, Yang XD, Liblau RS, Mcdevitt HO: Administering glutamic acid decarboxylase to NOD mice prevents diabetes. J Autoimmun 7:845-850, 1994
10. Elliott JF, Qin HY, Bhatti S, Smith DK, Singh RK, Dillon T, Lauzon J, Singh B: Immunization with the larger isoform of mouse glutamic acid decarboxylase (GAD67) prevents autoimmune diabetes in NOD mice. Diabetes 43:1494-1499, 1994
11. Petersen JS, Karlsen AE, Markholst H, Worsaae A, Dyrberg T, Michelsen B: Neonatal tolerization with glutamic acid decarboxylase but not with bovine serum albumin delays the onset of diabetes in NOD mice. Diabetes 43:1478-1484, 1994
12. Pleau JM, Fernandez Saravia F, Esling A, Homo Delarche F, Dardenne M: Prevention of autoimmune diabetes in nonobese diabetic female mice by treatment with recombinant glutamic acid decarboxylase (GAD 65). Clin Immunol Immunopathol 76:90-95, 1995
13. Tian J, Lehmann PV, Kaufman DL: T cell cross-reactivity between Coxsackie and glutamate decarboxylase is associated with a murine diabetes susceptibility allele. J Exp Med 180:1979-1984, 1994
14. + Th1 cells induce diabetes in NOD/SCID mice. J Clin Invest 101:68-73, 1998
15. Petersen JS, Russel S, Marshall MO, Kofod H, Buschard K, Cambon N, Karlsen AE, Boel E, Hagopian WA, Hajnaes KR, Moody A, Dryberg T, Lernmark A, Madsen OD, Michelsen BK: Differential expression of glutamic acid decarboxylase in rat and human islets. Diabetes 42:484-495, 1993
16. Kim J, Richter W, Aanstoot H-J, Shi Y, Fu Q, Rajotte R, Warnock G, Baekkeskov S: Differential expression of GAD65 and GAD67 in human, rat, and mouse pancreatic islets. Diabetes 42:1799-1808, 1993
17. Faulkner-Jones BE, Cram DS, Kun J, Harrison LC: Localization and quantitation of expression of two glutamate decarboxylase genes in pancreatic beta-cells and other peripheral tissues of mouse and rat. Endocrinology 133:2962-2972, 1993
18. Velloso LA, Bjork E, Ballagi AE, Funa K, Andersson A, Kampe O, Karlsson FA, Eizirik DL: Regulation of GAD expression in islets of Langerhans occurs both at the mRNA and protein level. Mol Cell Endocrinol 102:31-37, 1994
19. Pleau J, Esling A, Vanacker C, Dardenne M: Glutamic acid decarboxylase (GAD 67) gene expression in the pancreas and brain of the nonobese diabetic mouse. Biochem Biophys Res Commun 224:747-753, 1996
20. Pleau J, Throsby M, Esling A, Dardenne M: Ontogeny of glutamic-acid decarboxylase gene expression in the mouse pancreas. Biochem Biophys Res Comm 233:227-230, 1997
21. Saravia-Fernandez R, Faveeuw C, Blasquez-Bulant C, Tappaz M, Throsby M, Pelletier G, Vaudry H, Dardenne M, Homo-Delarche F: Localization of γ-aminobutyric acid and glutamic acid decarboxylase in the pancreas of the nonobese diabetic mouse. Endocrinology 137:3497-3506, 1996
22. a donors. Diabetes 42:44-55, 1993
23. Gerling IC, Serreze DV, Christianson SW, Leiter EH: Intrathymic islet cell transplantation reduces beta cell autoimmunity and prevents diabetes in NOD/Lt mice. Diabetes 41:1672-1676, 1992
24. Gotoh M, Maki T, Kiyoizumi T, Satomi S, Monaco AP: An improved method for the isolation of mouse pancreatic islets. Transplantation 40:437-438, 1985
25. Laemmli UK: Cleavage of structural proteins during the assembly of the head of the bacteriophage T4. Nature 227:680-685, 1970
26. Wu J-Y, Denner L, Lin C-T, Song G: L-glutamate decarboxylase from brain. In Methods in Enzymology. Colowick S, Kaplan N, Eds. New York, Academic Press, 1985, p. 3-10
27. Hanson MS, Cetkovic-Cvrlje M, Ramiya V, Atkinson M, Maclaren N, Singh B, Elliott J, Serreze D, Leiter E: Quantitative thresholds of MHC Class II I-E expression on hematopoietically derived APC in transgenic NOD/Lt mice determine level of diabetes resistance and indicate mechanism of protection. J Immunol 157:1279-1287, 1996
28. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:152-159, 1987
29. Anderson JT, Cornelius JG, Jarpe AJ, Winter WE, Peck AB: Insulin-dependent diabetes in the NOD mouse model. II. β-cell destruction in autoimmune diabetes is a Th2 and not a Th1 mediated event. Autoimmunity 15:113-122, 1993
30. Liu ZH, Striker LJ, Hattori M, Yang CW, Striker GE: Localization of glutamic acid decarboxylase in the kidneys of nonobese diabetic mice. Nephron 72:662-666, 1996
31. Shultz LD, Schweitzer PA, Christianson SW, Gott B, Birdsall-Maller I, Tennent B, McKenna S, Mobraaten L, Rajan TV, Greiner DL, Leiter EH: Multiple defects in innate and adaptive immunological function in NOD/LtSz-scid mice. J Immunol 154:180-191, 1995
32. Petersen JS, Mackay P, Plesner A, Karlsen A, Gotfredsen C, Verland S, Michelsen B, Dyrberg T: Treatment with GAD65 or BSA does not protect against diabetes in BB rats. Autoimmunity 25:129-138, 1997
33. Panina-Bordignon P, Lang R, Vanendert PM, Benazzi E, Felix AM, Pastore RM, Spinas GA, Sinigaglia F: Cytotoxic T cells specific for glutamic acid decarboxylase in autoimmune diabetes. J Exp Med 181:1923-1927, 1995
34. Liblau RS, Singer SM, McDevitt HO: Th1 and Th2 CD4(+) T cells in the pathogenesis of organ-specific autoimmune diseases. Immunol Today 16:34-38, 1995
35. Jolicoeur C, Hanahan D, Smith KM: T-cell tolerance toward a transgenic β-cell antigen and transcription of endogenous pancreatic genes in thymus. Proc Natl Acad Sci U S A 91:6707-6711, 1994
36. Smith K, Olson D, Hirose R, Hanahan D: Pancreatic gene expression in rare cells of thymic medulla: evidence for functional contribution to T cell tolerance. Int Immunol 9:1355-1365, 1997
37. Pugliese A, Zeller M, Fernandez A Jr, Zalcberg L, Bartlett R, Ricordi C, Pietropaolo M, Eisenbarth G, Bennett S, Patel D: The insulin gene is transcribed in the human thymus and transcription levels correlate with allelic variation at the INS VNTR-IDDM2 susceptibility locus for type 1 diabetes. Nat Genet 15:293-297, 1997
38. Vafiadis P, Bennett S, Todd J, Nadeau J, Grabs R, Goodyer C, Wickramasingher S, Colle E, Polychronakos C: Insulin expression in human thymus is modulated by INS VNTR alleles at the IDDM2 locus. Nat Genet 15:289-292, 1997
39. Cetkovic-Cvrlje M, Gerling IC, Muir A, Atkinson MA, Elliot JF, Leiter EH: Diabetes retardation or acceleration in NOD/Lt mice mediated by intrathymic administration of candidate beta cell autoantigens. Diabetes 46:1975-1982, 1997
40. Gilon P, Bertrand G, Loubatieres-Mariani M, Remacle C, Henquin J: The influence of γ-aminobutyric acid on hormone release by the mouse and rat endocrine pancreas. Endocrinology 129:2521-2529, 1991
41. Fox C, Danska J: IL-4 expression at the onset of islet inflammation predicts nondestructive insulitis in nonobese diabetic mice. J Immunol 158:2414-2424, 1997
42. O'Garra A: Cytokines induce the development of functionally heterogeneous T helper cell subsets. Cell 8:275-283, 1998
43. g7 transgenic nonobese diabetic mouse line. Diabetes 46:1970-1974, 1997
44. Jhappan C, Morse HCI, Fleischmann RD, Gottesman MM, Merlino G: DNA-PKCs: a T-cell tumor suppressor encoded at the mouse scid locus. Nat Genet 17:483-486, 1997